Cargando…
Identification of beta-arrestin-1 as a diagnostic biomarker in lung cancer
BACKGROUND: Distinguishing lung adenocarcinoma (ADC) from squamous cell carcinoma (SCC) has a tremendous therapeutic implication. Sometimes, the commonly used immunohistochemistry (IHC) markers fail to discriminate between them, urging for the identification of new diagnostic biomarkers. METHODS: We...
Autores principales: | El-Khoury, Victoria, Béland, Mélanie, Schritz, Anna, Kim, Sang-Yoon, Nazarov, Petr V., Gaboury, Louis, Sertamo, Katriina, Bernardin, François, Batutu, Roxane, Antunes, Laurent, Bennett, Catherine W., Faÿs, François, Berchem, Guy, Kim, Yeoun Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6162208/ https://www.ncbi.nlm.nih.gov/pubmed/30078843 http://dx.doi.org/10.1038/s41416-018-0200-0 |
Ejemplares similares
-
Identification of a Blood-Based Protein Biomarker Panel for Lung Cancer Detection
por: El-Khoury, Victoria, et al.
Publicado: (2020) -
Assessing cellular and circulating miRNA recovery: the impact of the RNA isolation method and the quantity of input material
por: El-Khoury, Victoria, et al.
Publicado: (2016) -
Cell-free DNA and next-generation sequencing in the service of personalized medicine for lung cancer
por: Bennett, Catherine W., et al.
Publicado: (2016) -
Triphenylmethane Dye Activation of Beta-Arrestin
por: Barak, Larry S., et al.
Publicado: (2013) -
The actin filament cross-linker L-plastin confers resistance to TNF-α in MCF-7 breast cancer cells in a phosphorylation-dependent manner
por: Janji, Bassam, et al.
Publicado: (2010)